The potential drug is Naloxone which is used to reverse the respiratory-depressant effect of an opioid.
The widely used opioid-receptor blocker naloxone provides a good standard safety cover for opioid-induced respiratory depression reversal. Naloxone-induced respiratory depression reversal. Since opioid analgesia and respiratory depression derive from the same product of the gene, use of naloxone will inevitably result in reduction or probably even loss of analgesic effectiveness.
